The Manufacturers Life Insurance Company Buys 4,774 Shares of Sotera Health (NASDAQ:SHC)

The Manufacturers Life Insurance Company raised its stake in shares of Sotera Health (NASDAQ:SHC) by 4.3% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 115,065 shares of the company’s stock after acquiring an additional 4,774 shares during the period. The Manufacturers Life Insurance Company’s holdings in Sotera Health were worth $1,366,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. CWM LLC increased its position in shares of Sotera Health by 86.1% during the 2nd quarter. CWM LLC now owns 2,146 shares of the company’s stock valued at $25,000 after purchasing an additional 993 shares during the last quarter. Point72 DIFC Ltd increased its position in shares of Sotera Health by 556.6% during the 2nd quarter. Point72 DIFC Ltd now owns 6,540 shares of the company’s stock valued at $78,000 after purchasing an additional 5,544 shares during the last quarter. Acadian Asset Management LLC increased its position in shares of Sotera Health by 728.0% during the 2nd quarter. Acadian Asset Management LLC now owns 9,381 shares of the company’s stock valued at $111,000 after purchasing an additional 8,248 shares during the last quarter. Sandia Investment Management LP purchased a new stake in shares of Sotera Health during the 1st quarter valued at $120,000. Finally, Securian Asset Management Inc. increased its position in shares of Sotera Health by 23.0% during the 1st quarter. Securian Asset Management Inc. now owns 10,178 shares of the company’s stock valued at $122,000 after purchasing an additional 1,900 shares during the last quarter. 91.03% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on SHC shares. Barclays lifted their price objective on Sotera Health from $14.00 to $17.00 and gave the stock an “overweight” rating in a report on Tuesday, August 6th. Royal Bank of Canada reissued an “outperform” rating and issued a $17.00 price objective on shares of Sotera Health in a report on Tuesday, August 6th. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $15.70.

Insider Activity

In other news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of Sotera Health stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $15.03, for a total transaction of $150,300,000.00. Following the completion of the sale, the director now owns 49,215,301 shares in the company, valued at approximately $739,705,974.03. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 55.12% of the company’s stock.

Sotera Health Stock Up 0.8 %

SHC stock opened at $15.32 on Friday. The company has a quick ratio of 2.59, a current ratio of 2.93 and a debt-to-equity ratio of 5.46. The firm has a market capitalization of $4.34 billion, a PE ratio of 109.43 and a beta of 2.07. Sotera Health has a twelve month low of $10.71 and a twelve month high of $17.44. The stock has a 50-day simple moving average of $15.68 and a two-hundred day simple moving average of $13.14.

Sotera Health (NASDAQ:SHC) last issued its quarterly earnings results on Monday, August 5th. The company reported $0.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.15 by $0.04. The firm had revenue of $277.00 million during the quarter, compared to the consensus estimate of $266.45 million. Sotera Health had a return on equity of 47.26% and a net margin of 3.65%. The company’s revenue for the quarter was up 8.6% on a year-over-year basis. During the same quarter last year, the company posted $0.19 EPS. On average, equities analysts predict that Sotera Health will post 0.64 EPS for the current fiscal year.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.